Economic evaluation of stapokibart for chronic rhinosinusitis with nasal polyps in China: a cost-effectiveness analysis.

Yang J, Ren L, Xie F, Shao R, Jiang R

Open source

DOI
10.57264/cer-2025-0189
Published
2026 Jun
Container
Journal of comparative effectiveness research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.57264/cer-2025-0189,
  title = {Economic evaluation of stapokibart for chronic rhinosinusitis with nasal polyps in China: a cost-effectiveness analysis.},
  author = {Yang J and Ren L and Xie F and Shao R and Jiang R},
  year = {2026},
  journal = {Journal of comparative effectiveness research},
  doi = {10.57264/cer-2025-0189},
  url = {https://doi.org/10.57264/cer-2025-0189}
}

RIS

TY  - JOUR
TI  - Economic evaluation of stapokibart for chronic rhinosinusitis with nasal polyps in China: a cost-effectiveness analysis.
AU  - Yang J
AU  - Ren L
AU  - Xie F
AU  - Shao R
AU  - Jiang R
PY  - 2026
JO  - Journal of comparative effectiveness research
DO  - 10.57264/cer-2025-0189
UR  - https://doi.org/10.57264/cer-2025-0189
ER  - 

APA

J, Y., L, R., F, X., R, S., & R, J. (2026). Economic evaluation of stapokibart for chronic rhinosinusitis with nasal polyps in China: a cost-effectiveness analysis.. Journal of comparative effectiveness research. https://doi.org/10.57264/cer-2025-0189

Source records